Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry
In: BMC Cardiovascular disorders, Jg. 21 (2021-06-12), Heft 1
Online
serialPeriodical
Zugriff:
Titel: |
Feasibility and safety of cangrelor in patients with suboptimal P2Y(12) inhibition undergoing percutaneous coronary intervention: rationale of the Dutch Cangrelor Registry
|
---|---|
Autor/in / Beteiligte Person: | Selvarajah, A. ; Tavenier, A. H. ; Bor, W. L. ; Houben, Alfons J. H. M. ; Rasoul, S. ; Kaplan, E. ; Teeuwen, K. ; Hofma, S. H. ; Lipsic, E. ; Amoroso, G. ; van Leeuwen, M. A. H. ; ten Berg, J. M. ; van 't Hof, A. W. J. ; Hermanides, R. S. ; Cardiologie ; RS: Carim - B04 Clinical thrombosis and Haemostasis ; MUMC+: MA Med Staf Spec Cardiologie (9) ; RS: Carim - H01 Clinical atrial fibrillation |
Link: | |
Zeitschrift: | BMC Cardiovascular disorders, Jg. 21 (2021-06-12), Heft 1 |
Veröffentlichung: | 2021 |
Medientyp: | serialPeriodical |
ISSN: | 1471-2261 (print) |
DOI: | 10.1186/s12872-021-02093-4 |
Sonstiges: |
|